Literature DB >> 29528684

Word-list intrusion errors predict progression to mild cognitive impairment.

Kelsey R Thomas1, Joel Eppig2, Emily C Edmonds3, Diane M Jacobs4, David J Libon5, Rhoda Au6, David P Salmon4, Mark W Bondi1.   

Abstract

OBJECTIVE: Preclinical Alzheimer's disease (AD) defined by a positive AD biomarker in the presence of normal cognition is presumed to precede mild cognitive impairment (MCI). Subtle cognitive deficits and cognitive inefficiencies in preclinical AD may be detected through process and error scores on neuropsychological tests in those at risk for progression to MCI.
METHOD: Cognitively normal participants (n = 525) from the Alzheimer's Disease Neuroimaging Initiative were followed for up to 5 years and classified as either stable normal (n = 305) or progressed to MCI (n = 220). Cox regressions were used to determine whether baseline process scores on the Rey Auditory Verbal Learning Test (AVLT; intrusion errors, learning slope, proactive interference, retroactive interference) predicted progression to MCI and a Clinical Dementia Rating (CDR) score of 1 after considering demographic characteristics, apolipoprotein E ε4 status, cerebrospinal fluid AD biomarkers, ischemia risk, mood, functional difficulty, and standard neuropsychological total test scores for the model.
RESULTS: Baseline AVLT intrusion errors predicted progression to MCI (hazard ratio = 1.04, 95% confidence interval 1.01-1.07, p = .008) and improved model fit after the other valuable predictors were already in the model, χ2(df = 1) = 6.330, p = .012. AVLT intrusion errors also predicted progression to CDR = 1 (hazard ratio = 1.10, 95% confidence interval 1.02-1.18, p = .016) and again improved model fit, χ2(df = 1) = 4.682, p = .030.
CONCLUSIONS: Intrusion errors on the AVLT contribute unique value for predicting progression from normal cognition to MCI and normal cognition to mild dementia (CDR = 1). Intrusion errors appear to reflect subtle change and inefficiencies in cognition that precede impairment detected by neuropsychological total scores. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29528684      PMCID: PMC5851458          DOI: 10.1037/neu0000413

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  49 in total

1.  Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.

Authors:  Heiko Braak; Dietmar R Thal; Estifanos Ghebremedhin; Kelly Del Tredici
Journal:  J Neuropathol Exp Neurol       Date:  2011-11       Impact factor: 3.685

2.  Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis.

Authors:  Catherine M Roe; Chengjie Xiong; J Phillip Miller; John C Morris
Journal:  Neurology       Date:  2007-01-16       Impact factor: 9.910

3.  Leukoaraiosis severity and list-learning in dementia.

Authors:  Catherine C Price; Kelly Davis Garrett; Angela L Jefferson; Stephanie Cosentino; Jared J Tanner; Dana L Penney; Rodney Swenson; Tania Giovannetti; Brianne Magouirk Bettcher; David J Libon
Journal:  Clin Neuropsychol       Date:  2009-08       Impact factor: 3.535

4.  Task decomposition analysis of intertrial free recall performance on the Rey Auditory Verbal Learning Test in normal aging and Alzheimer's disease.

Authors:  J L Woodard; J A Dunlosky; T A Salthouse
Journal:  J Clin Exp Neuropsychol       Date:  1999-10       Impact factor: 2.475

5.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

6.  Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.

Authors:  K Welsh; N Butters; J Hughes; R Mohs; A Heyman
Journal:  Arch Neurol       Date:  1991-03

7.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

8.  Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults.

Authors:  M W Bondi; D P Salmon; A U Monsch; D Galasko; N Butters; M R Klauber; L J Thal; T Saitoh
Journal:  Neurology       Date:  1995-12       Impact factor: 9.910

9.  Semantic interference deficits and the detection of mild Alzheimer's disease and mild cognitive impairment without dementia.

Authors:  David A Loewenstein; Amarilis Acevedo; Cheryl Luis; Thomas Crum; Warren W Barker; Ranjan Duara
Journal:  J Int Neuropsychol Soc       Date:  2004-01       Impact factor: 2.892

10.  Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.

Authors:  Katherine J Bangen; Alexandra L Clark; Madeline Werhane; Emily C Edmonds; Daniel A Nation; Nicole Evangelista; David J Libon; Mark W Bondi; Lisa Delano-Wood
Journal:  J Alzheimers Dis       Date:  2016-03-29       Impact factor: 4.472

View more
  22 in total

1.  Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.

Authors:  Kelsey R Thomas; Emily C Edmonds; Joel Eppig; David P Salmon; Mark W Bondi
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

2.  Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.

Authors:  Kelsey R Thomas; Jessica R Osuna; Alexandra J Weigand; Emily C Edmonds; Alexandra L Clark; Sophia Holmqvist; Isabel H Cota; Christina E Wierenga; Mark W Bondi; Katherine J Bangen
Journal:  J Cereb Blood Flow Metab       Date:  2020-07-02       Impact factor: 6.200

3.  Type 2 Diabetes Interacts With Alzheimer Disease Risk Factors to Predict Functional Decline.

Authors:  Kelsey R Thomas; Katherine J Bangen; Alexandra J Weigand; Emily C Edmonds; Erin Sundermann; Christina G Wong; Joel Eppig; Madeleine L Werhane; Lisa Delano-Wood; Mark W Bondi
Journal:  Alzheimer Dis Assoc Disord       Date:  2020 Jan-Mar       Impact factor: 2.703

4.  New Intrusion Analyses on the CVLT-3: Utility in Distinguishing the Memory Disorders of Alzheimer's versus Huntington's Disease.

Authors:  Lisa V Graves; Heather M Holden; Emily J Van Etten; Lisa Delano-Wood; Mark W Bondi; David P Salmon; Jody Corey-Bloom; Paul E Gilbert; Dean C Delis
Journal:  J Int Neuropsychol Soc       Date:  2019-05-07       Impact factor: 2.892

5.  Changes in LASSI-L performance over time among older adults with amnestic MCI and amyloid positivity: A preliminary study.

Authors:  Marcela Kitaigorodsky; Rosie E Curiel Cid; Elizabeth Crocco; Katherine L Gorman; Christian J González-Jiménez; Maria Greig-Custo; Warren W Barker; Ranjan Duara; David A Loewenstein
Journal:  J Psychiatr Res       Date:  2021-08-26       Impact factor: 4.791

6.  Visuospatial performance in patients with statistically-defined mild cognitive impairment.

Authors:  Victor Wasserman; Sheina Emrani; Emily F Matusz; Jamie Peven; Seana Cleary; Catherine C Price; Terrie Beth Ginsberg; Rodney Swenson; Kenneth M Heilman; Melissa Lamar; David J Libon
Journal:  J Clin Exp Neuropsychol       Date:  2020-01-24       Impact factor: 2.475

7.  Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes.

Authors:  Jacob D Jones; Carmen Uribe; Joseph Bunch; Kelsey R Thomas
Journal:  J Neurol       Date:  2020-08-17       Impact factor: 4.849

8.  Mayo Normative Studies: Regression-Based Normative Data for the Auditory Verbal Learning Test for Ages 30-91 Years and the Importance of Adjusting for Sex.

Authors:  Nikki H Stricker; Teresa J Christianson; Emily S Lundt; Eva C Alden; Mary M Machulda; Julie A Fields; Walter K Kremers; Clifford R Jack; David S Knopman; Michelle M Mielke; Ronald C Petersen
Journal:  J Int Neuropsychol Soc       Date:  2020-08-20       Impact factor: 2.892

9.  Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration.

Authors:  Kelsey R Thomas; Katherine J Bangen; Alexandra J Weigand; Emily C Edmonds; Christina G Wong; Shanna Cooper; Lisa Delano-Wood; Mark W Bondi
Journal:  Neurology       Date:  2019-12-30       Impact factor: 11.800

10.  Intrusion Errors and Progression of Cognitive Deficits in Older Adults with Mild Cognitive Impairment and PreMCI States.

Authors:  Elizabeth A Crocco; Rosie Curiel Cid; Marcela Kitaigorodsky; Gabriella A Grau; Jessica M Garcia; Ranjan Duara; Warren Barker; Cesar L Chirinos; Rosemarie Rodriguez; David A Loewenstein
Journal:  Dement Geriatr Cogn Disord       Date:  2021-06-23       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.